More Men Seeking Psychedelic-Assisted Therapy for Mental Health Conditions

Mental health awareness has become popular in the recent past, with more individuals being open about discussing their struggles with mental health while more organizations and people also advocate for proper steps and assistance to be provided to those in need. Given that June is Men’s Mental Health month, it’s only fitting that we promote overall wellness while raising awareness about issues and health care trends that impact men.

More men have been discussing mental health more openly, which helps shatter cultural stigmas. This trend is a break from past patterns as traditionally, mental health has not been a typical topic of conversation for men. This change has allowed more men to seek treatment for various mental health conditions, including substance abuse, post-traumatic stress disorder, depression and anxiety.

One of the most popular treatments for brain optimization and mental health conditions is psychedelic-assisted therapy. Practitioners and researchers are trying to learn more about the natural treatment approach as it gains support from state legislatures and interest from candidates seeking alternative treatments.

Psychedelic-assisted therapy uses psychedelics for healing purposes. In this approach, patients have a psychedelic administered under a therapist’s supervision. There are challenges with the treatment, however, including some ambiguity and considerations when choosing a treatment. So, how can those interested in providing psychedelic-assisted therapy or legally exploring the substances go about this?

Psychable is a broad online community that may be helpful to practitioners as well as individuals seeking treatment and support for their psychedelic journeys. The community can be accessed at Psychable.com.

Psychable’s chief strategy officer and co-founder Matt Zemon stated that while the stigma surrounding men who seek mental health treatment may still exist at some level, he applauds all those who prioritize their holistic well-being and seek care for their mental health. He explained that research had demonstrated psychedelics’ ability to treat various mental health conditions as well as their transformative power as medicine, adding that the community was passionate about enlightening men about their options for acquiring psychedelic-assisted therapy legally.

Psychable offers those who would like to learn more about psychedelic-assisted therapy a safe place to not only interact with their peers and share their experiences but also connect with trusted practitioners. The community’s networks allow users to review practitioners and share recommendations; it also facilitates direct communication between patients and practitioners who would like to talk about various treatment plans. The community is open to all who are interested in learning more about psychedelic-assisted therapy or finding practitioners who can be of assistance.

If the observation that more men are opening up on matters of mental health is anything to go by, companies such as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), which is engaged in developing psychedelic-based remedies for neuropsychiatric conditions, are likely to serve a large market once their planned products get regulatory approval.

NOTE TO INVESTORS: The latest news and updates relating to Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) available in the company’s newsroom at https://ibn.fm/TRYPF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.